The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.
The development of gene delivery systems for therapeutic use involves vectors (often retrovirus or adenovirus) which typically encode one target protein, but the use of internal ribosome entry sites (IRES) can confer the ability to express more than one protein from bi- or polycistronic mRNAs. IRES...
主要な著者: | Chung, G, Yamada, Y, Pannell, R, Forster, A, Rabbitts, T |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2003
|
類似資料
-
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
著者:: Yamada, Y, 等
出版事項: (2002) -
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
著者:: Yamada, Y, 等
出版事項: (2000) -
RNA-Protein Interactome at the Hepatitis E Virus Internal Ribosome Entry Site
著者:: Shiv Kumar, 等
出版事項: (2023-08-01) -
IRESpy: an XGBoost model for prediction of internal ribosome entry sites
著者:: Junhui Wang, 等
出版事項: (2019-07-01) -
Polypyrimidine-Tract-Binding Protein Isoforms Differentially Regulate the Hepatitis C Virus Internal Ribosome Entry Site
著者:: Jenniffer Angulo, 等
出版事項: (2022-12-01)